Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical Nitroglycerin for Pedal Artery Dilation
NCT04155476Phase 1Unknown
- Sponsor
- Deborah Heart and Lung Center
- Start
- Dec 2019
- Primary completion
- Mar 2020
- Modality
- Small Molecules
01
Overview
Phase 1, randomised, double-blind trial of nitroglycerin in Peripheral Arterial Disease (PAD) (2 arms), sponsored by Deborah Heart and Lung Center. Primary endpoint: Vessel Diameter of Posterior Tibial and Dorsalis Pedis Arteries at 90 months. Status: unknown.
02
Drugs
nitroglycerin
03
Conditions
Peripheral Arterial Disease (PAD)
Beyond the preview
Go deeper on NCT04155476.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04155476.